IL-17A increases ADP-induced platelet aggregation

Biochemical and Biophysical Research Communications

Volumn 408, Issue 4, 2011, Pages 658-662

  Maione, Francesco ^a,b   Cicala, Carla ^b   Liverani, Elisabetta ^a   Mascolo, Nicola ^b   Perretti, Mauro ^a   D'Acquisto, Fulvio ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Autoimmune diseases; Inflammation; Interleukin 17A; Platelet aggregation

Indexed keywords

ADENOSINE DIPHOSPHATE; FIBRINOGEN; GLYCOPROTEIN IB ALPHA; INTERLEUKIN 17; MITOGEN ACTIVATED PROTEIN KINASE 1; PADGEM PROTEIN; PHOSPHOSPECIFIC ANTIBODY;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; BINDING SITE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE AGGREGATION; TURBIDITY;

ADENOSINE DIPHOSPHATE; ADULT; ANIMALS; AUTOIMMUNE DISEASES; FEMALE; HUMANS; INTERLEUKIN-17; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MIDDLE AGED; PLATELET AGGREGATION; RECEPTORS, INTERLEUKIN-17; THROMBOEMBOLISM;

MURINAE;

EID: 79956219285     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.080     Document Type: Article

References (28)

1. Onishi R.M., Gaffen S.L. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010, 129:311-321.
2. D'Acquisto F., Maione F., Pederzoli-Ribeil M. From IL-15 to IL-33: the never-ending list of new players in inflammation. Is it time to forget the humble aspirin and move ahead?. Biochem. Pharmacol. 2010, 79:525-534.
3. Lubberts E. Th17 cytokines and arthritis. Semin. Immunopathol. 2010, 32:43-53.
4. Zhang Z., Kyttaris V.C., Tsokos G.C. The role of IL-23/IL-17 axis in lupus nephritis. J. Immunol. 2009, 183:3160-3169.
5. Chen X.Q., Yu Y.C., Deng H.H., Sun J.Z., Dai Z., Wu Y.W., Yang M. Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity. J. Clin. Immunol. 2010, 30:221-225.
6. Zhao X.F., Pan H.F., Yuan H., Zhang W.H., Li X.P., Wang G.H., Wu G.C., Su H., Pan F.M., Li W.X., Li L.H., Chen G.P., Ye D.Q. Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol. Biol. Rep. 2010, 37:81-85.
7. Leipe J., Grunke M., Dechant C., Reindl C., Kerzendorf U., Schulze-Koops H., Skapenko A. Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum. 2010, 62:2876-2885.
8. Mameli A., Barcellona D., Marongiu F. Rheumatoid arthritis and thrombosis. Clin. Exp. Rheumatol. 2009, 27:846-855.
9. Pitchford S.C. Novel uses for anti-platelet agents as anti-inflammatory drugs. Br. J. Pharmacol. 2007, 152:987-1002.
10. Ye P., Rodriguez F.H., Kanaly S., Stocking K.L., Schurr J., Schwarzenberger P., Oliver P., Huang W., Zhang P., Zhang J., Shellito J.E., Bagby G.J., Nelson S., Charrier K., Peschon J.J., Kolls J.K. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 2001, 194:519-527.
11. Moraes L.A., Paul-Clark M.J., Rickman A., Flower R.J., Goulding N.J., Perretti M. Ligand-specific glucocorticoid receptor activation in human platelets. Blood 2005, 106:4167-4175.
12. Pearce A.C., Senis Y.A., Billadeau D.D., Turner M., Watson S.P., Vigorito E. Vav1 and vav3 have critical but redundant roles in mediating platelet activation by collagen. J. Biol. Chem. 2004, 279:53955-53962.
13. Pederzoli-Ribeil M., Maione F., Cooper D., Al-Kashi A., Dalli J., Perretti M., D'Acquisto F. Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature. Blood 2010, 116:4288-4296.
14. Leung L., Nachman R. Molecular mechanisms of platelet aggregation. Annu. Rev. Med. 1986, 37:179-186.
15. Murugappa S., Kunapuli S.P. The role of ADP receptors in platelet function. Front Biosci. 2006, 11:1977-1986.
16. Maione F., Paschalidis N., Mascolo N., Dufton N., Perretti M., D'Acquisto F. Interleukin 17 sustains rather than induces inflammation. Biochem. Pharmacol. 2009, 77:878-887.
17. Adam F., Kauskot A., Rosa J.P., Bryckaert M. Mitogen-activated protein kinases in hemostasis and thrombosis. J. Thromb. Haemost. 2008, 6:2007-2016.
18. Garcia A., Shankar H., Murugappan S., Kim S., Kunapuli S.P. Regulation and functional consequences of ADP receptor-mediated ERK2 activation in platelets. Biochem. J. 2007, 404:299-308.
19. Andoh A., Yasui H., Inatomi O., Zhang Z., Deguchi Y., Hata K., Araki Y., Tsujikawa T., Kitoh K., Kim-Mitsuyama S., Takayanagi A., Shimizu N., Fujiyama Y. Interleukin-17 augments tumor necrosis factor-alpha-induced granulocyte and granulocyte/macrophage colony-stimulating factor release from human colonic myofibroblasts. J. Gastroenterol. 2005, 40:802-810.
20. Woltman A.M., de Haij S., Boonstra J.G., Gobin S.J., Daha M.R., van Kooten C. Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J. Am. Soc. Nephrol. 2000, 11:2044-2055.
21. Clemetson K.J., Clemetson J.M. Platelet GPIb-V-IX complex. Structure, function, physiology, and pathology. Semin. Thromb. Hemost. 1995, 21:130-136.
22. Wohner N. Role of cellular elements in thrombus formation and dissolution. Cardiovasc. Hematol. Agents Med. Chem. 2008, 6:224-228.
23. Furman M.I., Barnard M.R., Krueger L.A., Fox M.L., Shilale E.A., Lessard D.M., Marchese P., Frelinger A.L., Goldberg R.J., Michelson A.D. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J. Am. Coll. Cardiol. 2001, 38:1002-1006.
24. Hu H., Li N., Yngen M., Ostenson C.G., Wallen N.H., Hjemdahl P. Enhanced leukocyte-platelet cross-talk in Type 1 diabetes mellitus: relationship to microangiopathy. J. Thromb. Haemost. 2004, 2:58-64.
25. Irving P.M., Macey M.G., Shah U., Webb L., Langmead L., Rampton D.S. Formation of platelet-leukocyte aggregates in inflammatory bowel disease. Inflamm. Bowel Dis. 2004, 10:361-372.
26. Joseph J.E., Harrison P., Mackie I.J., Isenberg D.A., Machin S.J. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br. J. Haematol. 2001, 115:451-459.
27. Hot A L.V., M-A Cazalis, P Miossec Pathogenic role of IL-17 in endothelial dysfunction a link between rheumatoid arthritis and atherosclerosis. Ann. Rheum. Dis. 2010, 69:44-45.
28. Hueber W., Patel D.D., Dryja T., Wright A.M., Koroleva I., Bruin G., Antoni C., Draelos Z., Gold M.H., Durez P., Tak P.P., Gomez-Reino J.J., Foster C.S., Kim R.Y., Samson C.M., Falk N.S., Chu D.S., Callanan D., Nguyen Q.D., Rose K., Haider A., Di Padova F. a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci. Transl. Med. 2010, 2. 52ra72.